HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Abild Stengaard Meyer Selected Research

Martin Abild Stengaard Meyer Research Topics

Disease

5Out-of-Hospital Cardiac Arrest
12/2023 - 11/2021
4Coma (Comas)
12/2023 - 11/2021
2Kidney Diseases (Kidney Disease)
05/2024 - 05/2023
2Heart Arrest (Cardiac Arrest)
12/2023 - 12/2023
2Brain Injuries (Brain Injury)
01/2023 - 11/2021
2Inflammation (Inflammations)
01/2023 - 11/2021
1Hypotension (Low Blood Pressure)
12/2023
1Hypertension (High Blood Pressure)
12/2023
1Cardiogenic Shock
05/2023
1Acute Kidney Injury (Acute Renal Failure)
05/2023
1ST Elevation Myocardial Infarction
05/2023
1Post-Cardiac Arrest Syndrome
11/2021
1Wounds and Injuries (Trauma)
02/2013
1Traumatic Brain Injuries (Traumatic Brain Injury)
02/2013
1Neck Injuries (Neck Injury)
02/2013

Drug/Important Bio-Agent (IBA)

3Biomarkers (Surrogate Marker)IBA
05/2023 - 02/2013
2CreatinineIBA
12/2023 - 05/2023
2C-Reactive ProteinIBA
05/2023 - 11/2021
2tocilizumab (atlizumab)FDA Link
01/2023 - 11/2021
2Phosphopyruvate Hydratase (Enolase)IBA
01/2023 - 11/2021
1Oxygen (Dioxygen)IBA
12/2023
1Lipocalin-2IBA
05/2023
1Trinitrotoluene (TNT)IBA
01/2023
1pro-brain natriuretic peptide (1-76)IBA
01/2023
1CytokinesIBA
01/2023
1Troponin T (Troponin T1)IBA
11/2021
1MB Form Creatine KinaseIBA
11/2021
1Interleukin-6 (Interleukin 6)IBA
11/2021
1AntibodiesIBA
11/2021
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
11/2021
1Brain Natriuretic Peptide (Natrecor)FDA Link
11/2021
1Hemostatics (Antihemorrhagics)IBA
02/2013

Therapy/Procedure

1Renal Replacement Therapy (Therapies, Renal Replacement)
05/2024
1Critical Care (Surgical Intensive Care)
12/2023
1Induced Hypothermia
11/2021
1Resuscitation
11/2021